These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 5839673)
1. [Effect of phosphocreatinine in a case of essential hyperlipemia]. Kissel P; Schmitt J; Duc M; Vaillant G Ann Med Nancy; 1965; 4():642-9. PubMed ID: 5839673 [No Abstract] [Full Text] [Related]
3. [Treatment of essential hyperlipemia with clofibrate]. Reuter W; Seifert A Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292 [No Abstract] [Full Text] [Related]
4. [Drugs for hyperlipemia]. Murakami M; Sekimoto H; Masuda S; Nagai T; Iwaki N Naika; 1968 Oct; 22(4):877-85. PubMed ID: 5710974 [No Abstract] [Full Text] [Related]
5. [The effect of Atromid treatment of patients with essential hyperlipidemia and xanthomatosis]. Baranova LV Ter Arkh; 1967 Jul; 39(7):61-3. PubMed ID: 5610932 [No Abstract] [Full Text] [Related]
6. Divergent effects in the treatment of hyperlipemia. Slowe IA; Carter AC; Feldman EB Arch Intern Med; 1965 Oct; 116(4):523-30. PubMed ID: 5835355 [No Abstract] [Full Text] [Related]
7. [Medical treatment of hyperlipemia. Indications and modern preparations]. Frey H Tidsskr Nor Laegeforen; 1968 Jan; 88(2):6-8. PubMed ID: 5663311 [No Abstract] [Full Text] [Related]
8. [Clinical and biological aspects of hyperlipemia]. Turcanu V; Bartl F; Fiat F Med Interna (Bucur); 1970 Apr; 22(4):489-93. PubMed ID: 4246119 [No Abstract] [Full Text] [Related]
9. [Antagonist action of lipoxidase on hyperlipemia induced by Triton WR-1339 in rats]. Freyss-Beguin M C R Seances Soc Biol Fil; 1969 Feb; 162(7):1316-9. PubMed ID: 4238876 [No Abstract] [Full Text] [Related]
10. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases]. Warembourg H; Jaillard J Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637 [No Abstract] [Full Text] [Related]
12. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia]. Martínez-Castelao A Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262 [No Abstract] [Full Text] [Related]
13. [Case of essential (idiopathic) hyperlipidemia]. Shkhvatsabaia LV; Kozhevnikova TL; Iurgavichus EK Klin Med (Mosk); 1974 Jan; 52(1):139-42. PubMed ID: 4466879 [No Abstract] [Full Text] [Related]
15. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons]. Rilliet B; Monnier J Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485 [No Abstract] [Full Text] [Related]
16. Clofibrate and androsterone effect on serum lipids. Orgain ES; Bogdonoff MD; Cain C Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838 [No Abstract] [Full Text] [Related]
17. [Action of ethyl chlorophenoxyisobutyrate on several types of hyperlipidemia]. Beaumont V; Swynghedauw B; Beaumont JL; Himbert J Rev Atheroscler (Paris); 1966; 8(1):12-20. PubMed ID: 5961026 [No Abstract] [Full Text] [Related]
18. Criteria for use of hypolipidemic agents in adults. Morales E; Spinler SA; Wilson MD; Chin MM; Jozefiak E Am J Hosp Pharm; 1994 Nov; 51(22):2837-41. PubMed ID: 7856612 [No Abstract] [Full Text] [Related]